GRANULOMATOSIS WITH POLYANGIITIS
Clinical trials for GRANULOMATOSIS WITH POLYANGIITIS explained in plain language.
Never miss a new study
Get alerted when new GRANULOMATOSIS WITH POLYANGIITIS trials appear
Sign up with your email to follow new studies for GRANULOMATOSIS WITH POLYANGIITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vaccine trial offers hope for vulnerable patients in dengue zones
⭐️ VACCINE ⭐️ Not yet recruitingThis study is testing whether a single-dose dengue vaccine is safe and works well for people with autoimmune diseases like rheumatoid arthritis or lupus. Researchers will compare about 320 patients with these conditions to 160 healthy volunteers, all living in areas where dengue …
Matched conditions: GRANULOMATOSIS WITH POLYANGIITIS
Phase: PHASE4 • Sponsor: University of Sao Paulo General Hospital • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:35 UTC
-
New hope for controlling debilitating GPA symptoms in the ears, nose, and throat
Disease control Not yet recruitingThis study is testing if adding the drug TAVNEOS to standard treatment helps people with granulomatosis with polyangiitis (GPA) better control their ear, nose, and throat symptoms. About 30 participants with active GPA affecting these areas will receive either TAVNEOS or a placeb…
Matched conditions: GRANULOMATOSIS WITH POLYANGIITIS
Phase: PHASE2, PHASE3 • Sponsor: Robert Spiera, MD • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC